Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzastaurin + Pemetrexed + Cisplatin in Advanced NSCLC
NCT00538681Phase 2Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of enzastaurin in non-small cell lung cancer (NSCLC), sponsored by Eli Lilly and Company. Started Sep 2007; status: terminated.
02
Drugs
enzastaurin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00538681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00538681.